Oban Intersects 17.22 g/t Au Over 3.9 Metres at Windfall

TORONTO, ONTARIO--(May 12, 2016) - Oban Mining Corporation (OBM.TO) ("Oban" or the "Corporation") is pleased to announce new results from the ongoing drill program at its 100% owned Windfall Lake gold project located in Urban - Barry Townships, Québec. The 55,000 metre drill program combines definition drilling above the Red Dog intrusion ("Red Dog") and expansion drilling above and below Red Dog.
 
Highlights from 16 new drill holes include: 17.22 g/t Au over 3.9 metres in DDH OBM-16-642; 25.2 g/t Au over 2.3 metres in DDH OBM-16-643; 9.94 g/t Au over 5.3 metres in DDH OBM-16-651; and 9.55 g/t Au over 2.4 metres in DDH OBM-16-649. The new results continue to demonstrate lateral and vertical continuity of high grade gold mineralization in Zone 27 and the Caribou Zone, and also highlights new zones continuing to develop between these two major mineralized corridors. The table below outlines significant new results(1)(2):
Read more: Oban Mining Corporation ( OBM )

Histogenics Corporation Announces First Quarter 2016 Financial and Operating Results

- NeoCart® Phase 3 Clinical Trial Remains on Track for Enrollment Completion by End of Second Quarter of 2017 -
- Company to Host Conference Call and Webcast Today at 8:30 a.m. EDT -
 
WALTHAM, Mass., May 12, 2016  -- Histogenics Corporation (Histogenics) (HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, announced its financial and operational results for the quarter ended March 31, 2016. 
 
“We made significant progress on a number of important business objectives in the first quarter of 2016. Most importantly, we continued the positive enrollment trends we have seen over the last several months in the NeoCart Phase 3 clinical trial and remain confident that we are on track to complete patient enrollment by the end of the second quarter of 2017,” stated Adam Gridley, President and Chief Executive Officer of Histogenics.
Read more: Histogenics Corporation ( Histogenics )

NexGen Energy Ltd. - Hole AR-16-76c1 Returns 67.5 m at 11.29% U3O8 including 9.0 m at 51.35% U3O8 and 0.5 m at 79.80% U3O8

VANCOUVER, May 5, 2016 NexGen Energy Ltd. ("NexGen" or the "Company") (TSXV:NXE, OTCQX:NXGEF) is pleased to report assay results for thirteen angled holes from our highly successful winter 2016 drilling program on our 100% owned, Rook I property, Athabasca Basin, Saskatchewan.
Hole AR-16-76c1 has intersected 67.5 m at 11.29% U3O8 in the higher grade A2 sub-zone (the "Sub-Zone"). The intercept includes 9.0 m at 51.35% U3O8 and 0.5 m at 79.80% U3O8 which represents a continuous grade x thickness ("GT") of 762, the second best at the Arrow Deposit to date. Drill hole -76c1 intercepted the near vertically dipping mineralization at a shallow inclination of -65°.   All five drill holes reported in this release and drilled into the Sub-Zone have returned strong and broad intercepts of high grade mineralization (as determined by a total composite GT of >200) confirming strong continuity of the High Grade Domain.
In addition, holes AR-16-63c3, AR-16-64c3, AR-16-72c2 and AR-16-74c1 all intersected high grade uranium mineralization in the Sub-Zone. Assay results from AR-16-72c2 were higher than anticipated from the radioactivity results, and as such, the hole is now being included within the Sub-Zone.  
Read more: NexGen Energy Ltd ( NXE )

Eric Sprott Increases Newmarket Gold Shareholdings to 17.9% by Purchasing 16.2 Million Newmarket Common Shares at $2.80 Per Share

VANCOUVER, BRITISH COLUMBIA --  04/26/16 -- Newmarket Gold Inc. ("Newmarket" or the "Company") (TSX:NMI)(OTCQX:NMKTF) and Eric Sprott are pleased to report that Mr. Sprott will purchase 16,200,000 common shares of Newmarket (the "Acquired Shares") from Luxor Capital Partners LP and affiliates ("Luxor") at a price of $2.80 per Acquired Share for total consideration of $45.4 million. Together with Mr. Sprott's prior shareholdings in Newmarket, Mr. Sprott will own 31,351,196 common shares of Newmarket representing an approximate 17.9% ownership in the Company. Luxor also granted Mr. Sprott a right of first refusal to purchase up to an additional 22,000,000 common shares of Newmarket. This right expires December 31, 2016.

Mr. Sprott has been granted all voting rights attached to the Acquired Shares effective until the closing of the purchase of the Acquired Shares. Therefore, Mr. Sprott currently exercises control or direction over 31,351,196 common shares of Newmarket, representing approximately 17.9% of the issued and outstanding shares.

Read more: Newmarket Gold Inc ( NMI )

Biocept Continues International Expansion through Agreement with Quest Diagnostics Mexico

Biocept's Liquid Biopsy Test that Detects EGFR Mutations Associated with Lung Cancer to be Easily Accessible in Mexico

SAN DIEGOApril 18, 2016  -- Biocept, Inc. (NASDAQ: BIOC) continues to expand internationally by announcing that its Target Selector™ industry-leading blood-based test to detect EGFR mutations associated with lung cancer will now be accessible to patients in Mexico through a reference agreement with Quest Diagnostics Mexico.  Terms of the transaction were not disclosed.  Biocept is a leading molecular diagnostics company that commercializes and develops liquid biopsy tests for cancer profiling and monitoring.

Read more: Biocept Inc ( BIOC )

Videos / Webinars

View all videos

Pepperstone | Metatrader 4 Forex Broker